Zaloguj Zarejestruj się zadarmo

Acorda Therapeutics Inc organizacji Przychody Y / Y

Jaka jest wartość Przychody Y / Y organizacji Acorda Therapeutics Inc?

Wartość Przychody Y / Y organizacji Acorda Therapeutics Inc to -0.79%

Jaka jest definicja Przychody Y / Y?

Roczny wzrost przychodów z ostatnich 3 lat to wzrost przychodów z jednego roku do drugiego uśredniony w ciągu ostatnich 3 lat.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Przychody Y / Y firm w Health Care sektor na NASDAQ w porównaniu do Acorda Therapeutics Inc

Czym się zajmuję organizacja Acorda Therapeutics Inc?

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

Firmy z przychody y / y podobne do Acorda Therapeutics Inc